Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease

OBJECTIVES: Human anti-chimeric antibodies (HACAs) and subtherapeutic infliximab concentrations are associated with decreased duration of response. We evaluated the clinical utility of measuring HACA and infliximab concentrations. METHODS: The medical records of patients with inflammatory bowel dise...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Am J Gastroenterol
Auteurs principaux: Afif, Waqqas, Loftus, Edward V., Faubion, William A., Kane, Sunanda V., Bruining, David H., Hanson, Karen A., Sandborn, William J.
Format: Artigo
Langue:Inglês
Publié: 2010
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6937708/
https://ncbi.nlm.nih.gov/pubmed/20145610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ajg.2010.9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires